NO20055211L - Anti-fungale forbindelser og fremgangsmater for anvendelse - Google Patents

Anti-fungale forbindelser og fremgangsmater for anvendelse

Info

Publication number
NO20055211L
NO20055211L NO20055211A NO20055211A NO20055211L NO 20055211 L NO20055211 L NO 20055211L NO 20055211 A NO20055211 A NO 20055211A NO 20055211 A NO20055211 A NO 20055211A NO 20055211 L NO20055211 L NO 20055211L
Authority
NO
Norway
Prior art keywords
fungal
methods
fungal compounds
agents
compounds
Prior art date
Application number
NO20055211A
Other languages
English (en)
Other versions
NO20055211D0 (no
Inventor
Takumi Kawabe
Hidetaka Kobayashi
Original Assignee
Canbas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canbas Co Ltd filed Critical Canbas Co Ltd
Publication of NO20055211D0 publication Critical patent/NO20055211D0/no
Publication of NO20055211L publication Critical patent/NO20055211L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)

Abstract

Det beskrives forbindelser som inkluderer peptider og peptidomimetika med anti-fungal aktivitet alene, samt i kombinasjon med andre midler som har anti-fungal aktivitet. Videre beskrives anvendelsen av cellesyklus-G2-kontrollpunkt abrogatorer som anti-fungale midler som for eksempel anti-fungale medisiner.
NO20055211A 2003-04-07 2005-11-04 Anti-fungale forbindelser og fremgangsmater for anvendelse NO20055211L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46110903P 2003-04-07 2003-04-07
US10/819,375 US7125842B2 (en) 2003-04-07 2004-04-05 Anti-fungal compounds and methods of use
PCT/IB2004/001523 WO2004089396A2 (en) 2003-04-07 2004-04-07 Anti-fungal peptidomimetics

Publications (2)

Publication Number Publication Date
NO20055211D0 NO20055211D0 (no) 2005-11-04
NO20055211L true NO20055211L (no) 2006-01-05

Family

ID=33162249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055211A NO20055211L (no) 2003-04-07 2005-11-04 Anti-fungale forbindelser og fremgangsmater for anvendelse

Country Status (8)

Country Link
US (1) US7125842B2 (no)
EP (1) EP1613339A2 (no)
JP (1) JP4728220B2 (no)
KR (1) KR20060010742A (no)
AU (1) AU2004228783A1 (no)
CA (1) CA2521713A1 (no)
NO (1) NO20055211L (no)
WO (1) WO2004089396A2 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210745A1 (en) * 2002-09-09 2010-08-19 Reactive Surfaces, Ltd. Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
US20110070376A1 (en) * 2002-09-09 2011-03-24 Reactive Surfaces, Ltd. Anti-fouling Paints & Coatings
US20090238811A1 (en) * 2002-09-09 2009-09-24 Mcdaniel C Steven Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
US20040109853A1 (en) * 2002-09-09 2004-06-10 Reactive Surfaces, Ltd. Biological active coating components, coatings, and coated surfaces
US20100233146A1 (en) * 2002-09-09 2010-09-16 Reactive Surfaces, Ltd. Coatings and Surface Treatments Having Active Enzymes and Peptides
JP4705567B2 (ja) * 2003-06-25 2011-06-22 株式会社 キャンバス 免疫調整活性、抗炎症活性、および抗ウイルス活性を有するペプチドおよびペプチド模倣物
US8618066B1 (en) 2003-07-03 2013-12-31 Reactive Surfaces, Ltd., Llp Coating compositions having peptidic antimicrobial additives and antimicrobial additives of other configurations
CA2572960A1 (en) * 2004-07-06 2006-02-09 Susan E. Lewis Multifunctional compositions having combined insecticidal, mitacidal and fungicidal activity
US20060153786A1 (en) * 2004-12-10 2006-07-13 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
GB0428136D0 (en) * 2004-12-22 2005-01-26 Syngenta Participations Ag Novel materials and methods for the production thereof
US20060286006A1 (en) * 2005-06-21 2006-12-21 Mcdaniel C S Method and apparatus for the treatment of fluid waste streams
WO2007002120A2 (en) * 2005-06-23 2007-01-04 Duke University Fungicidal effect by regulating signal transduction pathways
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
KR20170016031A (ko) * 2007-07-26 2017-02-10 레반스 테라퓨틱스, 아이엔씨. 항미생물 펩티드, 조성물, 및 이용 방법
PE20091924A1 (es) * 2008-05-14 2010-01-04 Takeda Pharmaceutical Compuesto peptidico y su uso
UA107651C2 (en) * 2008-08-01 2015-02-10 Dow Agrosciences Llc Use of 5-fluorocytosine as a fungicide
US8388904B1 (en) 2008-12-22 2013-03-05 Reactive Surfaces, Ltd., Llp Equipment decontamination system and method
US20100283445A1 (en) * 2009-02-18 2010-11-11 Freescale Semiconductor, Inc. Integrated circuit having low power mode voltage regulator
US8319548B2 (en) * 2009-02-18 2012-11-27 Freescale Semiconductor, Inc. Integrated circuit having low power mode voltage regulator
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
US8400819B2 (en) * 2010-02-26 2013-03-19 Freescale Semiconductor, Inc. Integrated circuit having variable memory array power supply voltage
JP2014503532A (ja) * 2010-12-16 2014-02-13 ダウ アグロサイエンシィズ エルエルシー ５−フルオロシトシンとその他の殺真菌剤との相乗的殺真菌性相互作用
US8537625B2 (en) 2011-03-10 2013-09-17 Freescale Semiconductor, Inc. Memory voltage regulator with leakage current voltage control
WO2012149334A2 (en) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
US9035629B2 (en) 2011-04-29 2015-05-19 Freescale Semiconductor, Inc. Voltage regulator with different inverting gain stages
CN104395388A (zh) 2012-02-17 2015-03-04 安德森公司 含有聚乳酸的建筑构件
EP2906946A1 (en) 2012-10-09 2015-08-19 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
EP2906197A1 (en) 2012-10-09 2015-08-19 The Procter & Gamble Company Method of identifying synergistic cosmetic combinations
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
PT3013351T (pt) * 2013-06-24 2020-01-17 Canbas Co Ltd Péptidos e peptidomiméticos em utilizações e tratamentos combinados para subpopulações de pacientes com cancro
KR20170054190A (ko) * 2015-11-09 2017-05-17 (주)앰틱스바이오 진균 감염 치료 및 예방을 위한 신규한 키나아제 및 이들의 용도
KR102068470B1 (ko) * 2017-12-21 2020-01-22 대한민국 항진균 및 항염증 활성을 갖는 신균주 아쓰리니움 js0567 및 이의 용도
CN113056291B (zh) * 2018-08-17 2023-05-30 塞弗德公司 核酸去污方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
AU4957196A (en) * 1995-07-06 1997-02-05 Mogam Biotechnology Research Institute Novel antibiotic peptides
JPH11116597A (ja) * 1997-10-15 1999-04-27 Morinaga Milk Ind Co Ltd ペプチド誘導体および抗真菌剤
JP2000197499A (ja) * 1998-10-27 2000-07-18 Pola Chem Ind Inc 新規化合物及びその製造法
DK1218494T3 (da) * 1999-09-22 2005-08-08 Canbas Co Ltd Præparater og fremgangsmåder til inhibering af C2-cellecyklusstandsning og sensibilisering af celler til DNA-beskadigende midler
JP3472821B2 (ja) * 2000-12-08 2003-12-02 広島大学長 新規ペプチド、及び当該ペプチドを用いた組成物
IL162836A0 (en) * 2002-01-17 2005-11-20 Canbas Co Ltd Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

Also Published As

Publication number Publication date
WO2004089396A3 (en) 2005-01-06
US7125842B2 (en) 2006-10-24
US20040229801A1 (en) 2004-11-18
KR20060010742A (ko) 2006-02-02
CA2521713A1 (en) 2004-10-21
AU2004228783A1 (en) 2004-10-21
JP4728220B2 (ja) 2011-07-20
WO2004089396A2 (en) 2004-10-21
NO20055211D0 (no) 2005-11-04
EP1613339A2 (en) 2006-01-11
JP2007527852A (ja) 2007-10-04

Similar Documents

Publication Publication Date Title
NO20055211L (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
CR9078A (es) Derivado de bencimidazol ariloxi-sustituidos
CY1120267T1 (el) Αντισωματα ανταγωνιστες κατευθυνομενα εναντι πεπτιδιου σχετιζομενου με το γονιδιο καλσιτονινης για την θεραπευτικη αγωγη αθροιστικης κεφαλαλγιας
NO20053201L (no) Nye heterocykliske fluorglukosidderivater, legemidler inneholdende disse forbindelser og deres anvendelse.
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
BRPI0605921B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
NO20055525L (no) Vevsbeskyttende cytokinreseptorkompleks, assay for identifisering av vevsbeskyttende forbindelser og anvendelser derav
CR9365A (es) Compuestos y metodos para la inhibicion de la protein-cinasa raf
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
NO20073487L (no) Valg av pasienter for terapi med en HER-inhibitor
DE502006002198D1 (de) Ur erhöhung der permeabilität von unterirdischen, teinsformationen und zum lösen von carbonatischen und/oder carbonathaltigen verunreinigungen bei der erdölförderung
BRPI0811046A2 (pt) Composto de hidrazida heterocíclica e uso pesticida do mesmo.
NO20083153L (no) Kjemiske forbindelser
WO2004087758A3 (en) Il 13 receptor alpha 2 antibody and methods of use
ATE373665T1 (de) Benzo-kondensierte heteroarylamid-derivative von thienopyridinen nützlich als therapeutische agentien, entsprechende pharmazeutische zusammensetzungen, und methoden für ihre verwendung
ATE525377T1 (de) Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
NO20080462L (no) Krystallformer av astaxantin
NO20084882L (no) Krystallinske former A og B av et maleatsalt av 5-amino-3-(2'3'-di-o-acetyl-beta-D-ribofuranosyl)-3H-tiazolo[4,5-d] pyrimidin-2 on
UY29046A1 (es) Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su uso en terapia
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
BRPI0516981A (pt) inibidores de mif
BR112015021586A2 (pt) formulações de morfina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application